Bumetanide is a member of the class of benzoic acids that is 4-phenoxybenzoic acid in which the hydrogens ortho to the phenoxy group are substituted by butylamino and sulfamoyl groups. Bumetanide is a diuretic, and is used for treatment of oedema associated with congestive heart failure, hepatic and renal disease. Among its listed roles, it functions as a diuretic and an EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor. It is a sulfonamide, an amino acid and a member of benzoic acids. It is grouped under the following drug class(es): Diuretics. Its therapeutic use is listed as antihypertensives, cardiovascular and hyponatremia agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Bumex, Burinex and Lixil. Its PubChem CID is 2471.
Bumetanide
| CAS No | 28395-03-01 |
|---|---|
| Molecular Formula | C17H20N2O5S |
| Molecular Weight | 364.41 g/mol |
| Synonyms | 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Bumetanide is a member of the class of benzoic acids that is 4-phenoxybenzoic acid in which the hydrogens ortho to the phenoxy group are substituted by butylamino and sulfamoyl groups.
The listed CAS number is 28395-03-01.
The listed molecular formula is C17H20N2O5S.
The listed molecular weight is 364.41 g/mol.
3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid.
The source lists Bumex, Burinex and Lixil.